Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535.
In “Efficacy and safety of different doses of a slow release corticosteroid implant
for macular edema: meta-analysis of randomized controlled trials” published May 2015,
on page 2530, in Table 1 we have mistakenly stated the fluocinolone acetonide (FA)
intravitreal inserts as Retisert® in the Campochiaro et al study; they were in fact
the fluocinolone acetonide intravitreal inserts. We feel sorry about that, and we
will be more rigorous to avoid any unnecessary confusion in the future.